BlackRock Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

BlackRock Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,034	Closed	-$216K	–	3772
2016 Q2	$216K	Sell	2,034 -2,540	-56%	-$295K	﹤0.01%	2561
2016 Q1	$524K	Sell	4,574 -2,482	-35%	-$291K	﹤0.01%	2049
2015 Q4	$1M	Sell	7,056 -2,765	-28%	-$319K	﹤0.01%	1708
2015 Q3	$882K	Sell	9,821 -392	-4%	-$41.4K	﹤0.01%	1785
2015 Q2	$1.18M	Sell	10,213 -13,019	-56%	-$1.37M	﹤0.01%	1554
2015 Q1	$2.22M	Sell	23,232 -6,090	-21%	-$456K	﹤0.01%	1192
2014 Q4	$1.97M	Sell	29,322 -9,720	-25%	-$602K	﹤0.01%	1204
2014 Q3	$2.11M	Buy	39,042 +15,806	+68%	+$778K	﹤0.01%	1160
2014 Q2	$1.03M	Buy	23,236 +22,900	+6,815%	+$935K	﹤0.01%	1474
2014 Q1	$12K	Hold	336	–	–	﹤0.01%	3520
2013 Q4	$10K	Sell	336 -1,342	-80%	-$38.9K	﹤0.01%	3510
2013 Q3	$49K	Sell	1,678 -3,494	-68%	-$87.1K	﹤0.01%	3193
2013 Q2	$120K	Buy	+5,172	New	+$131K	﹤0.01%	2777

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors's CBPO Position: Q3 2016 in Review

BlackRock Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2016, closing a stake of 2,034 shares — an estimated $216K sold.

BlackRock Advisors first reported a position in CBPO in Q2 2013 and held it in 13 quarters. The position peaked at $2.22M in Q1 2015. 162 funds tracked by Wall St. Rank hold CBPO as of Q3 2016.

BlackRock Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
BlackRock Advisors sold 2,034 China Biologic Products Holdings, Inc. shares in Q3 2016, an estimated $216K.
BlackRock Advisors first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 13 quarters.
BlackRock Advisors's China Biologic Products Holdings, Inc. position peaked at $2.22M in Q1 2015.
162 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2016.

Based on BlackRock Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.